Santhera and ReveraGen announce first patient with Becker muscular dystrophy dosed in FDA-funded pilot study
The first patient has been dosed in a phase 2 pilot study looking at a…
August 22, 2022 - 3 minutes
The first patient has been dosed in a phase 2 pilot study looking at a…